Bilieye

Non-invasive Remotely Solution for Monitoring Jaundice in Newborns

Health Tech & Life Sciences
Active
Pre-Seed Haifa Founded 2024
Total raised
$700K
Last: Pre-Seed 2025-03
Stage
Pre-Seed
Founded
2024
Headcount
3
HQ
Haifa
Sector
Health Tech & Life Sciences

About

Bilieye is redefining neonatal care with a revolutionary, non-invasive app that allows parents and healthcare providers to monitor a baby’s bilirubin levels remotely using just a photo of the baby’s eyes.

Bilirubin, a substance in the blood, can indicate liver dysfunction or conditions like jaundice when present in high levels. Jaundice is common in newborns, affecting 60-80% of babies during their first week of life. Currently, bilirubin levels are monitored through invasive blood tests that often require painful heel pricks, repeated hospital visits, and added stress for families.

Bilieye cutting-edge technology provides a simple, stress-free alternative, allowing parents to take a quick photo of their baby’s eyes with their smartphone to monitor bilirubin levels accurately and safely. Its software is designed to work for babies of all skin tones, ensuring that every family has access to this essential health monitoring tool.

The company's mission is to enhance the healthcare experience for families by providing a safe, effective, and accessible alternative to traditional bilirubin monitoring.

Funding history · 1 round · $700K total

2025-03
Pre-Seed $700K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftware
Target customers
ConsumersDemographics & FamilyBabiesHealthcare & Life SciencesHealthcarePatients
Business model
B2B2C

Highlights

1 PatentsVerified

Tags

babiesdigital-healthcarediagnostics